RAP
Click for more information
0.00% 20.5¢ resapp health limited

A new Beginning..., page-3411

  1. RNClarke
    1,428 Posts.
    lightbulb Created with Sketch. 855
    clock Created with Sketch.
    19/11/19
    10:34
    Post #: 41501404
    HeraMed's product is nothing revolutionary, doppler based foetal monitors already exist and have been approved in the past.

    ResApp's diagnostic product for children is a very different approval process.

    The Global Head of Diagnostics for Roche ($380B Market Cap) Tim Jaeger believes the digital transformation will drive better clinical decisions and diagnosis. They would be all over ResApp.

    RAP Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 29  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.